首页> 外国专利> Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies

Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies

机译:突变的HEV多肽及其在测定抗HEV抗体中的用途

摘要

Polypeptides of the p-ORF2 protein of the hepatitis E virus, including at least the amino acid sequence 394-660, numbered in relation to a p-ORF2 protein of 660 amino acids, in which the three cysteines at positions 627, 630 and 638 have been mutated or, for a p-ORF2 protein of different length, at least the amino acid sequence corresponding to amino acids 394-660 of the p-ORF2 protein of 660 amino acids, in which the three cysteines located at the three positions corresponding to positions 627, 630 and 638 of the p-ORF2 protein of 660 amino acids have been mutated. Also, methods for determining the presence of the humoral response or the titer of antibodies directed against the p-ORF2 protein using these polypeptides, and also the use thereof in the context of infection with the hepatitis E virus.
机译:戊型肝炎病毒p-ORF2蛋白的多肽,至少包含氨基酸序列394-660,相对于660个氨基酸的p-ORF2蛋白编号,其中三个半胱氨酸分别位于627、630和638位已经被突变,或者对于不同长度的p-ORF2蛋白,至少对应于660个氨基酸的p-ORF2蛋白的氨基酸394-660的氨基酸序列,其中三个半胱氨酸分别位于三个位置p-ORF2蛋白的660个氨基酸的627、630和638位已经突变。同样,使用这些多肽确定针对p-ORF2蛋白的体液应答或抗体滴度的存在的方法,以及其在戊型肝炎病毒感染的情况下的用途。

著录项

  • 公开/公告号US10408841B2

    专利类型

  • 公开/公告日2019-09-10

    原文格式PDF

  • 申请/专利权人 BIOMERIEUX;

    申请/专利号US201615774366

  • 申请日2016-11-29

  • 分类号C12N15;C12N15/86;C12N15/861;C12N7;A61K9/51;G01N33/576;C07K14/005;C07K14/10;C07K16/10;

  • 国家 US

  • 入库时间 2022-08-21 12:12:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号